Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intestinal disposition of sulindac in healthy volunteers
2019-001496-36Phase 4Completed
- Sponsor
- KU Leuven
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of sulindac, sponsored by KU Leuven. Primary endpoint: Intestinal and systemic disposition of sulindac. Started Jun 2019; status: completed.
02
Drugs
sulindac
Beyond the preview
Go deeper on 2019-001496-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-001496-36.